{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:07:44Z","timestamp":1746763664056,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5KL2TR002015-06"],"award-info":[{"award-number":["5KL2TR002015-06"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ogc.2024.12.012","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:38:05Z","timestamp":1738845485000},"page":"207-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rhesus D Immune Globulin in Early Pregnancy"],"prefix":"10.1016","volume":"52","author":[{"given":"Stevie L.","family":"Muscarella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianne","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2024.12.012_bib1","unstructured":"World Health Organization, Abortion care guideline, Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/349316\/9789240039483-eng.pdf (Accessed\u00a020 September 2024)."},{"key":"10.1016\/j.ogc.2024.12.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.07.002","article-title":"Society of Family Planning committee consensus on Rh testing in early pregnancy","volume":"114","author":"Horvath","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.ogc.2024.12.012_bib3","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. (2024). ACOG Clinical Practice Update: Rh D immune globulin administration after abortion or pregnancy loss at less than 12 weeks of gestation. Obstetrics & Gynecology, 144(6), e140-e143. Available at: https:\/\/doi.org\/10.1097\/AOG.0000000000005733 (Accessed 28 September 2024).","DOI":"10.1097\/AOG.0000000000005733"},{"year":"2005","series-title":"Blood groups and red cell antigens [internet]","author":"Dean","key":"10.1016\/j.ogc.2024.12.012_bib4"},{"year":"2014","series-title":"Mollison\u2019s Blood Transfusion in Clinical Medicine","author":"Klein","key":"10.1016\/j.ogc.2024.12.012_bib5"},{"issue":"Suppl 18","key":"10.1016\/j.ogc.2024.12.012_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"105","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.012_bib7","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"issue":"9","key":"10.1016\/j.ogc.2024.12.012_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7209a1","article-title":"Abortion surveillance \u2014 United States, 2021","volume":"72","author":"Kortsmit","year":"2023","journal-title":"Surveillance Summaries"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.012_bib9","doi-asserted-by":"crossref","DOI":"10.1363\/psrh.12215","article-title":"Abortion incidence and service availability in the United States, 2020","volume":"54","author":"Jones","year":"2022","journal-title":"Perspect Sex Reprod Health"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.012_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0002-9378(71)90232-8","article-title":"Role of spontaneous abortion in Rh immunization","volume":"110","author":"Queenan","year":"1971","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.012_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9378(72)90765-X","article-title":"Do Rh-negative women with an early spontaneous abortion need Rh immune prophylaxis?","volume":"113","author":"Visscher","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.012_bib12","article-title":"Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunization","author":"Karanth","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.012_bib13","article-title":"Prevention of RhD alloimmunization: a comparison of four national guidelines","volume":"35","author":"Sperling","year":"2018","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2024.12.012_bib14","first-page":"1","article-title":"Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and The Netherlands","volume":"X","author":"Wiebe","year":"2019","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.012_bib15","doi-asserted-by":"crossref","first-page":"102449","DOI":"10.1016\/j.jogc.2024.102449","article-title":"Guideline No. 448: Prevention of Rh D Alloimmunization","volume":"46","author":"Fung-Kee-Fung","year":"2024","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ogc.2024.12.012_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2020.02.011","article-title":"The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization","volume":"102","author":"Horvath","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.ogc.2024.12.012_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.2023.16953","article-title":"Induced abortion and the risk of Rh sensitization","volume":"330","author":"Horvath","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ogc.2024.12.012_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235807","article-title":"Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children","volume":"15","author":"Pegoraro","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ogc.2024.12.012_bib19","unstructured":"Available at: https:\/\/www.ashp.org\/drug-shortages\/current-shortages\/drug-shortage-detail.aspx?id=1022&loginreturnUrl=SSOCheckOnly (Accessed 1 September 2024)."},{"key":"10.1016\/j.ogc.2024.12.012_bib20","unstructured":"American College of Obstetricians and Gynecologists. (2024, March.) Practice advisory: rho(D) immune globulin shortages, 2024. ACOG Clinical. Available at: http:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2024\/03rhod-immune-globulin-shortages (Accessed 1 September 2024)."},{"issue":"5","key":"10.1016\/j.ogc.2024.12.012_bib21","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2024.02.288","article-title":"Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12\u00a0weeks of gestation","volume":"230","author":"Prabhu","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2024.12.012_bib22","doi-asserted-by":"crossref","first-page":"110530","DOI":"10.1016\/j.contraception.2024.110530","article-title":"Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation","volume":"139","author":"Horvath","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.ogc.2024.12.012_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.09.009","article-title":"Barriers to abortion care and incidence of attempted self-managed abortion among individuals searching Google for abortion care: a national prospective study","volume":"106","author":"Upadhyay","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.ogc.2024.12.012_bib24","unstructured":"Society of Family Planning. #WeCount Report: April 2022 to March 2024. Available at: https:\/\/doi.org\/10.46621\/97037hxrbsk."},{"issue":"16","key":"10.1016\/j.ogc.2024.12.012_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1 Suppl 1","key":"10.1016\/j.ogc.2024.12.012_bib26","first-page":"9","article-title":"Safety profile of WinRho anti-D","volume":"35","author":"Hong","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ogc.2024.12.012_bib27","unstructured":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), Guidelines for the use of Rh(D) immunoglobulin (Anti-D) in obstetrics (C-Obs 6). Interim update, 2023, RANZCOG. Available at: https:\/\/ranzcog.edu.au\/wp-content\/uploads\/Anti-D-Guidelines.pdf (Accessed 21 September 2024)."},{"issue":"10","key":"10.1016\/j.ogc.2024.12.012_bib28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.4419","article-title":"Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark","volume":"34","author":"Clausen","year":"2014","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.012_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","article-title":"Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium","volume":"48","author":"Minon","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.ogc.2024.12.012_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1254-4","article-title":"High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis","volume":"17","author":"Yang","year":"2019","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.012_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"7\u20138","key":"10.1016\/j.ogc.2024.12.012_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.gofs.2024.02.026","volume":"52","author":"Vigoureux","year":"2024","journal-title":"Gynecologie, obstetrique, fertilite & senologie"},{"key":"10.1016\/j.ogc.2024.12.012_bib35","unstructured":"Royal College of Obstetricians and Gynaecologists, Best practice in abortion care, 2022, Available at: https:\/\/www.rcog.org.uk\/media\/geify5bx\/abortion-care-best-practice-paper-april-2022.pdf (Accessed 21 September 2024)."}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854524001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854524001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:50:23Z","timestamp":1746759023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854524001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0889854524001177"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2024.12.012","relation":{},"ISSN":["0889-8545"],"issn-type":[{"type":"print","value":"0889-8545"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhesus D Immune Globulin in Early Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2024.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}